Century Therapeutics, Inc.
IPSC
$2.21
$0.094.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -391.18% | 92.43% | 79.61% | 82.28% | 83.56% |
| Total Depreciation and Amortization | -3.12% | -1.53% | -4.94% | -4.06% | -0.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.07% | -42.31% | -4.16% | -31.29% | -59.90% |
| Change in Net Operating Assets | 95.89% | -1,134.67% | -726.60% | -12,691.99% | -2,800.46% |
| Cash from Operations | 17.46% | 5.68% | 0.11% | -17.76% | -28.12% |
| Capital Expenditure | -963.33% | -450.65% | -16.43% | 97.19% | 99.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -200.00% | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -143.61% | 89.28% | 153.89% | 760.60% | 45.34% |
| Cash from Investing | -151.74% | 126.40% | 226.24% | 26,112.07% | 54.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 121.89% | -99.77% | -99.84% | -99.48% | 206.62% |
| Repurchase of Common Stock | -- | -- | -69.10% | -69.10% | -69.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 124.25% | -99.77% | -100.64% | -100.28% | 604.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.10% | -68.11% | 274.87% | 169.13% | 114.62% |